Protein-protein interactions as therapeutic targets in neuropsychopharmacology

Neuropsychopharmacology. 2009 Jan;34(1):247-8. doi: 10.1038/npp.2008.167.

Authors

Matthew T Reilly¹, Kathryn A Cunningham, Amarnath Natarajan

Affiliation

¹ Department of Pharmacology and Toxicology, Program in Chemical Biology and Center for Addiction Research, University of Texas Medical Branch, Galveston, TX, USA.

PMID: 19079071
DOI: 10.1038/npp.2008.167

No abstract available

Publication types

Review

MeSH terms

Animals
Basic-Leucine Zipper Transcription Factors / antagonists & inhibitors
Breast Neoplasms / drug therapy
Carrier Proteins / antagonists & inhibitors
Central Nervous System Diseases / drug therapy
Drug Delivery Systems / methods*
Fanconi Anemia Complementation Group Proteins / antagonists & inhibitors
Female
Homer Scaffolding Proteins
Humans
Neuropharmacology / methods*
Ovarian Neoplasms / drug therapy
Protein Interaction Domains and Motifs / drug effects*
Psychopharmacology / methods*
Rats
Receptors, Neurotransmitter / agonists
Receptors, Neurotransmitter / antagonists & inhibitors
Tumor Suppressor Proteins / antagonists & inhibitors
Ubiquitin Thiolesterase / antagonists & inhibitors

Substances

BACH1 protein, human
BAP1 protein, human
Basic-Leucine Zipper Transcription Factors
Carrier Proteins
Fanconi Anemia Complementation Group Proteins
Homer Scaffolding Proteins
Receptors, Neurotransmitter
Tumor Suppressor Proteins
Ubiquitin Thiolesterase